Cargando…
Mandibular mucormycosis following SARS-CoV-2 infection – A case report and review of literature
BACKGROUND: The second wave of COVID-19 pandemic has seen an unprecedented rise in the number of mucormycosis cases worldwide and in India particularly. This otherwise rare fungal infection has become an endemic among patients who have recovered from recent SARS-CoV-2 infection. Among the different...
Autores principales: | Ambereen, Aafiya, Rahman, Sajjad A., Rehman, Suhailur, Zaidi, Kamran, Arif, S.H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd on behalf of British Infection Association.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450209/ https://www.ncbi.nlm.nih.gov/pubmed/34568807 http://dx.doi.org/10.1016/j.clinpr.2021.100099 |
Ejemplares similares
-
A Case Series of Mucocutaneous Mucormycosis and its Risk Factors among SARS-CoV-2 Patients
por: Arora, Aakanksha, et al.
Publicado: (2022) -
Gross Hematuria following SARS-CoV-2 Vaccination
por: Sattari, Maryam, et al.
Publicado: (2023) -
Co-Occurrence of SARS-CoV-2 Infection and Inactivated SARS-CoV-2 Vaccination among Healthcare Workers
por: Cucunawangsih, Cucunawangsih, et al.
Publicado: (2021) -
Mucormycosis in post-covid patients: An epidemic in pandemic
por: Kesarwani, Vasudha, et al.
Publicado: (2022) -
The role of vaccination in COPD: influenza, SARS-CoV-2, pneumococcus, pertussis, RSV and varicella zoster virus
por: Simon, Susanne, et al.
Publicado: (2023)